Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative …
!["MYALEPTA Health Canada Approval"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/pexels-photo-11660582.jpeg?resize=600%2C400&ssl=1)
!["MYALEPTA Health Canada Approval"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/pexels-photo-11660582.jpeg?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative …
Chiesi Farmaceutici S.p.A (“Chiesi Group”), an international, research-focused biopharmaceuticals and healthcare group, and Oak Hill …